References

1. Venkatesh, S.; Lipper, R.A. "Role of the Development Scientist in Compound Lead Selection and Optimization," J. Pharm. Sci. 89, 145-154 (2000).

2. Gaviraghi, G.; Barnaby, R.J.; Pellegatti, M. "Pharmacokinetic Challenges in Lead Optimization," pp. 3-14 in Testa, B.; van de Waterbeemd, H.; Folkers, G.; Guy, R. eds., Pharmacokinetic Optimization in Drug Research. Biological, Physico-chemical and Computational Strategies, Verlag Helvetica Chimica Acta, Zurich (2001).

3. van de Waterbeemd, H.; Smith, D.A.; Beaumont, K.; Walker, D.K. "Property-based Design: Optimization of Drug Absorption and Pharmacokinetics," J. Med. Chem. 44, 1313-1332 (2001).

4. Caldwell, G.W. "Compound Optimization in Early- and Late-Phase Drug Discovery: Acceptable Pharmacokinetic Properties Utilizing Combined Physicochemical, In Vitro and In Vivo Screens," Curr. Opin. Drug Disc. Dev. 3, 30-41 (2000).

5. Smith, D.A. "High Throughput Drug Metabolism," pp. 137-143 in Gooderham, N., ed., Drug Metabolism: Towards the Next Millennium, IOS Press, London (1998).

6. Kramer, S.D. "Absorption Prediction From Physicochemical Parameters," Pharm. Sci. Technol. Today 2, 373-380 (1999).

7. Abraham, M.H.; Gola, J.M.R.; Kumarsingh, R.; Cometto-Muniz, J.E.; Cain, W.S. "Connection Between Chromatographic Data and Biological Data," J. Chro-matogr. B 745,102-115 (2000).

8. Sinko, P.J. "Drug Selection In Early Drug Development: Screening for Acceptable Pharmacokinetic Properties Using Combined In Vitro and Computational Approaches," Curr. Opin. Drug Disc. Dev. 2,42-48 (1999).

9. Barthe, L.; Woodley, J.; Houin, G. "Gastrointestinal Absorption of Drugs: Methods and Studies," Fund. Clin. Pharmacol. 13, 154-168 (1999).

10. Kerns, E.H. "High Throughput Physicochemical Profiling for Drug Discovery," J. Pharm. Sci. 90, 1838-1858 (2001).

11. Lin, J.H.; Rodrigues, A.D. "In Vitro Models for Early Studies of Drug Metabolism," pp. 217-243 in Testa, B.; van de Waterbeemd, H.; Folkers, G.; Guy, R., eds., Pharmacokinetic Optimization in Drug Research. Biological, Physico-chemical and Computational Strategies, Verlag Helvetica Chimica Acta, Zurich (2001).

12. Kleintop, T.; Liu, H.; Sarkaihan, A.; Sabus, C.; Zhang, M. "LC/UV/MS Method for Integrity Evaluation of Phamraceutical Discovery Compounds," in Proceedings of the Annual Conference of the American Association of Pharmaceutical Scientists, Denver, CO, October 21-24, 2004; Page 2343.

13. Valko, K.; Du, C.M.; Bevan, C.D.; Reynolds, D.; Abraham, M.H. "High Throughput Lipophilicity Determination: Comparison With Measured and Calculated Log P/Log D Values," Log P 2000 Conference, Laussanne, Switzerland, March 5-9, 2000.

14. Lombardo, F.; Shalaeva, M.Y.; Tupper, K.A.; Gao, F.; Abraham, M.H. "ElogPoct: A Tool for Lipophilicity Determination in Drug Discovery," J. Med. Chem. 43, 2922-2928 (2000).

15. Lombardo, F.; Shalaeva, M.Y.; Tupper, K.A.; Gao, F. "ElogDoct: A Tool for Lipophilicity Determination in Drug Discovery. 2. Basic and Neutral Compounds." J. Med. Chem. 44,2490-2497 (2001).

16. Kerns, E.H.; Di, L.; Petusky, S.; Kleintop, T.; McConnell, O.J., Carter, G. "Pharmaceutical Profiling Method for Lipophilicity and Integrity Using LC/MS," J. Chromatogr. B 791, 381-388 (2003).

17. Avdeef, A. "High Throughput Measurements of Solubility Profiles," pp. 305-326 in Testa, B.; van de Waterbeemd, H.; Folkers, G.; Guy, R., eds., Pharmacokinetic Optimization in Drug Research: Biological, Physiological, and Computational Strategies, Verlag Helvetica Chimica Acta, Zurich (2001).

18. Lipinski, C.A. "Avoiding Investment in Doomed Drugs," Curr. Drug Disc. April, 17-19 (2001).

19. Kansy, M.; Senner, F.; Gubernator, K. "Physicochemical High Throughput Screening: Parallel Artificial Membrane Permeability Assay in the Description of Passive Absorption Processes," J. Med. Chem. 41, 1007-1010 (1998).

20. Box, K.J.; Comer, J.E.A.; Hosking, P.; Tam, K.Y.; Trowbridge, L. "Rapid Physicochemical Profiling as an Aid to Drug Candidate Selection," pp. 67-74 in Dixon, G.K.; Major, J.S.; Rice, M.J., eds., High Throughput Screening: The Next Generation, BIOS Scientific Publishers Ltd., Oxford, UK (2000).

21. Di, L.; Kerns, E.H.; McConnell, O.J.; Carter, G. "High Throughput Artificial Membrane Permeability Assay for Blood-Brain Barrier," Eur. J. Med. Chem. 38, 223-232 (2003).

22. Kerns, E.H.; Di, L.; Kleintop, T.; Zhang, M.; Petusky, S.; McConnell, O. "High Throughput Stability Profiling for Drug Discovery," in Presented at the Symposium on Chemical and Pharmaceutical Structure Analysis, September, 2000.

23. Olah, T.V.; McLoughlin, D.A.; Gilbert, J.D. "The Simultaneous Determination of Mixtures of Drug Candidates by Liquid hromatography/Atmospheric Pressure Chemical Ionization Mass Spectrometry as an In Vivo Drug Screening Procedure,"

Rapid Commun. Mass Spectrom. 11,17-23 (1997).

24. Bayliss, M.K.; Frick, L.W. "High-Throughput Pharmacokinetics: Cassette Dosing," Curr. Opin. Drug Discovery Dev. 2, 20-25 (1999).

25. Halm, K.A.; Adkison, K.K.; Berman, J.; Shaffer, J.E.; Tong, Q.W.; Lee, F.W.; Unger, S.E. "Rapid In vivo Pharmacokinetic Screening of Drug Discovery Mixtures Using APCI LC/MC," in Proceedings of the 44th Annual Conference on Mass Spectrometry and Allied Topics, American Society for Mass Spectrometry, Santa Fe, 392(1996).

26. Gan, L.S.L.; Thakker, D.R. "Application of the Caco-2 Model in the Design and Development of Orally Active Drugs: Elucidation of Biochemical and Physical Barriers Posed by the Intestinal Epithelium," Adv. Drug Deliv. Rev. 23, 77-98 (1997).

27. Wold, S.; Albano, C.; Dunn, W.J., III; Edlund, U.; Esbensen, K.; Geladi, P.; Hellberg, S.; Johansson, E.; Lindberg, W.; Sjostrom, M. "Multivariate Analysis in Chemistry," pp. 17-95 in Kowalski, B.R., ed., Chemometrics. Mathematics and Statistics in Chemistry, D. Reidel, Dordrecht (Netherlands) (1984).

28. Eriksson, L.; Johnsson, J.; Sjostrom, M.; Wold, S. "A Strategy for Ranking En-viromentally Occurring Chemicals. Part II. An Illustration With Two Data Sets of Chlorinated Aliphatics and Aliphatic Alcohols," Chemom. Intell. Lab. Syst. 7, 131-141 (1989).

29. Grover, M.; Singh, B.; Bakshi, M.; Singh, S. "Quantitative Structure-Property Relationships in Pharmaceutical Research—Part 1," Pharm. Sci. Technol. Today 3, 28-35 (2000).

30. Grover, M.; Bakshi, M. "Quantitative Structure-Property Relationships in Pharmaceutical Research—Part 2," Pharm. Sci. Technol. Today 3, 50-57 (2000).

31. van de Waterbeemd, H.; Camenisch, G.; Folkers, G.; Raevsky, O.A. "Estimation of Caco-2 Cell Permeability Using Calculated Molecular Descriptors," Quant. Struct.-Act. Relat. 15,480-490 (1996).

32. Spencer, R.W. "High Throughput Screening of Historic Collections: Observations on File Size, Biological Targets, and File Diversity,"Biotechnol. Bioeng. (Comb. Chem.) 61, 61-67(1998).

33. Winiwarter, S.; Bonham, N.M.; Fredrick, A.; Hallberg, A.; Lennernas, H.; Karlen, A. "Correlation of Human Jejunal Permeability (In Vivo) of Drugs with Experimentally and Theoretically Derived Parameters. A Multivariate Data Analysis Approach," J. Med. Chem. 41,4939-4949 (1998).

34. Stenberg, P.; Norinder, U.; Luthman, K.; Artursson, P. "Virtual Screening of Intestinal Drug Permeability," J. Controlled Release 65, 231-243 (2000).

35. Stenberg, P.; Norinder, U.; Luthman, K.; Artursson, P. "Experimental and Computational Screening Models for the Prediction of Intestinal Drug Absorption," J. Med. Chem. 44, 1927-1937 (2001).

36. Egan, W.; Merz, K.M., Jr.; Baldwin, J.J. "Prediction of Drug Absorption Using Multivariate Statistics," J. Med. Chem. 43, 3867-3877 (2000).

37. Norinder,U.;Osterberg, T.; Artursson,P. "TheoreticalCalculationandPrediction of Caco-2 Cell Permeability Using MolSurf Parametrization andPLS Statistics," Pharm. Res. 14, 1786-1791 (1997).

38. Norinder, U.; (Osterberg, T.; Artursson, P. "Theoretical Calculation andPrediction of Intestinal Absorption of Drugs in Human Using MolSurf Parametrization and PLS Statistics," Eur. J. Pharm. Sci. 8,49-56 (1999).

39. Norinder, U.; (Osterberg, T. "Applicability of Computational Chemistry in the Evaluation and Prediction of Drug Transport Properties," Perspect. Drug Discovery Design 19, 1-18 (2000).

40. Sugawara, M.; Takekuma, Y.; Yamada, H.; Kobayashi, M.; Iseki, K.; Miyazaki, K. "A General Approach for the Prediction of Intestinal Absorption of Drugs: Regression Analysis Using the Physicochemical Properties and Drug-Membrane Electrostatic Interaction," J. Pharm. Sci. 87, 960-966 (1998).

41. Bravi, G.; Wikel, J.H. "Application of MS-WHIM Descriptors: 3. Prediction of Molecular Properties," Quant. Struct.-Act. Relat. 19, 39-49 (2000).

42. Norinder, U.; Sjoberg, P.; (Osterberg, T. "Theoretical Calculation and Predition of Brain-Blood Partitioning of Organic Solutes Using Mol Surf Parametrization and PLS Statistics," J. Pharm. Sci. 87, 952-959 (1998).

43. Luco, J.M. "Prediction of the Brain-Blood Distribution of a Large Set of Drugs from Structurally Derived Descriptors Using Partial Least-squares (PLS) Modeling." J. Chem. Inf. Comput. 39, 396-404 (1999).

44. (Osterberg, T.; Norinder, U. "Theoretical Calculation and Prediction of P-glycoprotein-Interaction Drugs Using MolSurf Parametrization and PLS Statistics." Eur. J. Pharm. Sci. 10, 295-303 (2000).

45. (Osterberg, T.; Norinder, U. "Prediction of Drug Transport Processes Using Simple Parameters and PLS Statistics: The Use of ACD/log P and ACD/ChemSketch Descriptors,"Eur. J. Pharm. Sci. 12, 327-337 (2001).

46. Schneider, G.; Coassolo, P.; Lave, T. "Combining In Vitro and In Vivo Pharmacokinetic Data for Prediction of Hepatic Drug Clearance in Humans by Artificial Neural Networks and Multivariate Statistical Techniques," J. Med. Chem. 42, 5072-5076 (1999).

47. Guba, W.; Cruciani, G. "Molecular Field-Derived Descriptors for the Multivariate Modeling of Pharmacokinetic Data," K. Gundertofte; and F.S. Jorgensen, eds., in Molecular Modeling and Prediction of Bioactivity, Kluwer Academic / Plenum Publishers, New York, 89-94 (2000).

48. van der Graaf, P.H.; Nilsson, J.; van Schaick, E.A.; Danhof, M. "Multivariate Quantitation Structure—Pharmacokinetic Relationships (QSPKR) Analysis of Adenosine Ai Receptor Agonists in Rat," J. Pharm. Sci. 88, 306-312 (1999).

49. Pickett, S.; McLay, I.M.; Clark, D.E. "Enhancing the Hit-to-Lead Properties of Lead Optimization Libraries," J. Chem. Inf. Comput. Sci. 40, 263-272 (2000).

50. Gedeck, P.; Willett, P. "Visual and Computational Analysis of Structure-Activity Relationships in High-Throughput Screening Data," Curr. Opin. Chem. Biol. 5, 389-395 (2001).

51. Kerns, E.H.; Di, L. "Pharmaceutical Profiling in Drug Discovery," Drug Disc. Today 8, 316-323 (2003).

52. Di, L.; Kerns, E.H. "Profiling Drug-like Properties in Discovery Research." Curr. Opin. Chem. Biol. 7,402-408 (2003).

53. McGovern, S.; Caselli, E.; Grigorieff, N.; Shoichet, B.K. "Common Mechanism Underlying Promiscuous Inhititors from Virtual and High-Throughput Screening," J. Med. Chem. 45, 1712-1722 (2002).

54. Wilson, D.M.; Wang, X.; Walsh, E.; Rourick, R. "High Throughput log D Determination Using Liquid Chromatography-Mass Spectrometry," Comb. Chem. High Throughput Screen 4, 511-519 (2001).

55. Avdeef, A.; Box, K.J.; Comer, J.E.A.; Hibbert, C.; Tam, K.Y. "pH-Metric LogP 10. Determination of Liposomal Membrane-Water Partition Coefficients of Ion-izable Drugs," Pharm. Res. 15, 209-215 (1998).

56. Lipiniski, C.A.; Lombardo, F.; Dominy, B.W.; Feeney, P.J. "Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings," Adv. Drug Delivery Rev. 23, 3-25 (1997).

57. Bevan, C.; Lloyd, R.S. "A High-Throughput Screening Method for the Determination of Aqueous Drug Solubility Using Laser Nephelometry in Microtiter Plates," Anal. Chem. 72, 1781-1787 (2000).

58. Avdeef, A. "pH—Metric Log P: Refinement of Partition Coefficients and Ionization Constants of Multiprotic Substances," J. Pharm. Sci. 82, 183-190 (1993).

59. Caldwell, G.W.; Easlick, S.M.; Gunnet, J.; Massucci, J.A.; Demarest, K. "In vitro Permeability of Eight ß-Blockers Through Caco-2 Monolayers Utilizing Liquid Chromatography/Electrospray Ionization Mass Spectrometry," J. Mass Spectrom. 33, 607-614 (1998).

60. Irvine, J. D.; Takahashi, L.; Lockhart, K.; Cheong, J.; Tolan, J.W.; Selick, H. E.; Grove, J.R. "MDCK (Madin-Darby Canine Kidney) Cells: A Tool for Membrane Permeability Screening," J. Pharm. Sci. 88, 28-33 (1999).

61. Caldwell, G.W.; Masucci, J.A.; Evangelisto, M.; White, R. "Evaluation of the Immobilized Artificial Membrane Phosphatidylcholine Drug Discovery Column for High Performance Liquid Chromatographic Screening of Drug-Membrane Interactions," J. Chromatogr. A 800, 161-169 (1998).

62. Wohnsland, F.; Faller, B. "High-Throughput Permeability pH Profile and High-Throughput Alkane/Water Log P With Artificial Membranes," J. Med. Chem. 44, 923-930 (2001).

63. Hill, A.; Bevan, C.; Reynolds, D. United Kingdom Patent W000/13328 (1999).

64. Korfmacher, W.A.; Cox, K.A.; Ng, K.J.; Veals, J.; Hsieh, Y.; Wainhaus, S.; Broske, L.; Prelusky, D.; Nomeir, A.; White, R.E. "Cassette-Accelerated Rapid Rat Screen: A Systematic Procedure for the Dosing and Liquid Chromatogra-phy/Atmospheric Pressure Ionization Tandem Mass Spectrometric Analysis of New Chemical Entities as Part of New Drug Discovery," Rapid Commun. Mass Spectrom. 15, 335-340 (2001).

65. McDonnell, P.A.; Caldwell, G.W.; Masucci, J.A. "Using Capillary Electrophore-sis/Frontal Analysis to Screen Drugs Interacting With Human Serum Proteins," Electrophoresis 19,448-454 (1998).

66. Kariv, I.; Cao, H.; Oldenberg, K.R. "Development of a High Throughput Equilibrium Dialysis Metho," J. Pharm. Sci. 90, 580-587 (2001).

67. Di, L.; Kerns, E.H.; Hong, Y.; Kleintop, T.; McConnell, O.J. "Optimization of a Higher Throughput Microsomal Stability Screening Assay for Profiling Drug Discovery Candidates," J. Biomol. Screening 8, 453-462 (2003).

68. Li, A.P.; Lu, C.; Brent, J.A.; Pham, C.; Fackett, A.; Ruegg, C.E.; Silber, P.M. "Cryopreserved Human Hepatocytes: Characterization of Drug-Metabolizing Enzyme Activities and Applications in Higher Throughput Screening Assays for Hepatotoxicity, Metabolic Stability, and Drug-Drug Interaction Potential," Chem. Biol. Interact. 121, 17-35 (1999).

69. Linget, J.; du Vignaud, P. "Automation of Metabolic Stability Studies in Microsomes, Cytosol and Plasma Using a 215 Gilson Liquid Handler," J. Pharm. Biomed. Anal. 19, 893-901 (1999).

70. Kerns, E.H.; Rourick, R.A.; Volk, K.J.; Lee, M.S. "Buspirone Metabolite Structure Profile Using a Standard Liquid Chromatographic-Mass Spectrometric Protocol," J. Chromatog. B 698, 133-145 (1997).

71. Burton, K.I.; Everett, J.R.; Newman, M.J.; Pullen, F.S.; Richards, D.S.; Swanson, A.G. "On-Line Liquid Chromatography Coupled with High Field NMR and Mass Spectrometry (LC-NMR-MS): A New Technique for Drug Metabolite Structure Elucidation," J. Pharm. Biomed. Anal. 15, 1903-1912 (1997).

72. Crespi, C.L. "Higher-Throughput Screening with Human Cytochromes P450," Curr. Opin. Drug Disc. Dev. 2, 15-19 (1999).

73. Dierks, E.A.; Stams, K.R.; Lim, H.K.; Cornelius, G.; Zhang, H.; Ball, S.E.A. "Method for the Simultaneous Evaluation of the Activities of Seven Major Human Drug-Metabolizing Cytochrome P450s Using an In Vitro Cocktail of Probe Substrates and Fast Gradient Liquid Chromatography Tandem Mass Spectrometry," Drug Metab. Dispos. 29,23-29 (2001).

74. Zhang, M. "Brain Uptake Studies Using LC/MS/MS," in Proceedings of the American Society for Mass Spectrometry. 49 th Annual Conference on Mass Spectrometry and Allied Topics, Santa Fe, NM (2001).

Was this article helpful?

0 0

Post a comment